24.01.2020 • News

Azelis Completes Megafarma Acquisition

Azelis Completes Megafarma Acquisition (c) Azelis
Azelis Completes Megafarma Acquisition (c) Azelis

Belgian chemical distributor Azelis, through its subsidiary Azelis Americas, has completed its acquisition of Megafarma, a Mexican specialty distributor for the pharma, food and veterinary industries.

Financial terms of the deal that was announced in December 2019 were not disclosed. The company founded in 1973 is headquartered at Mexico City and has a presence in Guadalajara and Monterrey.

Frank Bergonzi, CEO and president of Azelis Americas, said Megafarma, which posted double-digit sales growth in the period 2016 to 2018, will provide access to a promising market and create a strong platform for growth in the global specialty chemicals and food segments.

“Our expectation is to expand the strategic supplier relationships we have in the US and Canada in the food and pharma segments,” Bergzoni said. Through the acquisition, he said Azelis Americas will increase its Life Sciences footprint and will have a platform from which to enter other key market segments in Mexico.

All of Megafarma’s staff and operations will remain in place.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.